申请人:MERCK SHARP & DOHME
公开号:WO2012064569A1
公开(公告)日:2012-05-18
Described herein are compounds of formula (I), formula la or formula lb The compounds of formula I, formula la or formula lb act as DGATl inhibitors and can be useful in preventing, treating or acting as a remedial agent for hyperlipidemia, diabetes mellitus and obesity.
本文描述的是式(I)、式la或式lb的化合物。式(I)、式la或式lb的化合物作为DGATl抑制剂,在预防、治疗或作为治疗高脂血症、糖尿病和肥胖症的药物中可能有用。